PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
01-Jun-2022 Sales of Biotechnology Instruments Market Is Generating Highest Revenue With a CAGR of 16.4% During 2022 – 2032 |Fact.MR Study MARKITWIRED Latest Market Reports
01-Jun-2022 Increasing Utilization Of Bioelectric Medicine For The Treatment Of Different Cardiac Treatment To Drive Bioelectric Medicine Market MARKITWIRED Latest Market Reports
01-Jun-2022 Global Sales Of Nerve Monitoring Devices Is Forecast To Expand At Close To 5% CAGR During 2022-2032|Fact.MR Study MARKITWIRED Latest Market Reports
01-Jun-2022 Worldwide Demand For Facial Implant Is Likely To Expand At A CAGR Of 7.7% During 2022 – 2032| Fact.MR Forecasts MARKITWIRED Latest Market Reports
01-Jun-2022 The Hemoconcentration Market Is Expected To Show Significant Growth Due To The Rising Prevalence Of Cardiovascular Diseases MARKITWIRED Latest Market Reports
01-Jun-2022 Worldwide Demand For Smart Implants Is Anticipate To Expand At A CAGR Of 19% During 2022-2032| Fact.MR Forecasts MARKITWIRED Latest Market Reports
01-Jun-2022 Global Sales of Electrosurgery Devices Is Expected To Grow 1.5x By The End Of The Forecast Period During 2021-2031| Fact.MR Study MARKITWIRED Latest Market Reports
01-Jun-2022 The Demand For Preparative Chromatography Is Likely To Grow With The Increasing Demand For Large-Scale Integration Of Liquid Chromatography Techniques MARKITWIRED Latest Market Reports
01-Jun-2022 Demand For Anticoagulant Reversal Drugs To Witness An Outstanding Growth By 2026 | Fact.MR Study MARKITWIRED Latest Market Reports
01-Jun-2022 Relief Therapeutics Announces Results of Annual General Meeting of RELIEF THERAPEUTICS Holding SA Relief Therapeutics Holding SA
01-Jun-2022 Wound Irrigation Solution Market To Witness An Outstanding Growth By 2027 | Fact.MR Forecasts MARKITWIRED Latest Market Reports
01-Jun-2022 The Rise In Personalized Medicine Is Likely To Augment Retail Genomics Sales During 2022 to 2031 MARKITWIRED Latest Market Reports
31-May-2022 Vita 34 sees first signs of stabilization in core business after war-related weaker first quarter Vita 34 AG
31-May-2022 Median Technologies launches Imaging Lab, spearheading the integration of iBiopsy® Artificial Intelligence technologies into iCRO imaging services for oncology trials Median Technologies
31-May-2022 Clasado Biosciences has poster accepted at ISAPP 2022 Clasado Biosciences
31-May-2022 Transine Therapeutics Announces Final Closing of its Seed Round at £13.7m to Accelerate its Platform and Portfolio Development Transine Therapeutics
31-May-2022 Priothera Receives Fast Track Designation for mocravimod in Combination with Allogeneic Hematopoietic Stem Cell Transplant (HSCT) for Post Remission Therapy of Acute Myeloid Leukemia (AML) Patients Priothera
31-May-2022 ViiV Healthcare announces marketing approval by Japan’s Ministry of Health, Labour and Welfare for Vocabria (cabotegravir) used in combination with Rekambys (rilpivirine), the first and only complete long-acting treatment for HIV ViiV Healthcare
31-May-2022 FDA Approves Label Extension for Evrysdi® for Infants with Spinal Muscular Atrophy Under 2 Months Old PTC Therapeutics
31-May-2022 Update on Cialis® Rx-to-OTC Switch Actual Use Trial Sanofi